Αναπλαστικό ολιγοδενδρογλίωμα (Greek Wikipedia)

«The 2007 WHO classification of tumours of the central nervous system». Acta Neuropathol 114 (2): 97–109. August 2007. doi:10.1007/s00401-007-0243-4. PMID 17618441.
«Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis». Surg Neurol 60 (5): 443–56. November 2003. doi:10.1016/s0090-3019(03)00167-8. PMID 14572971.
Ostrom, Quinn T.; Gittleman, Haley; Liao, Peter; Vecchione-Koval, Toni; Wolinsky, Yingli; Kruchko, Carol; Barnholtz-Sloan, Jill S. (October 2017). «CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014». Neuro-Oncology 19 (S5): v1–v88. doi:10.1093/neuonc/nox158. PMID 29117289.
«Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors». Cancer 35 (5): 1398–404. May 1975. doi:10.1002/1097-0142(197505)35:5<1398::aid-cncr2820350524>3.0.co;2-c. PMID 1122488. https://archive.org/details/sim_cancer_1975-05_35_5/page/n149.
Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, Gutmann DH, Hervey-Jumper S, Kuner T, Mabbott D, Platten M, Rolls A, Sloan EK, Wang TC, Wick W, Venkataramani V, Monje M (April 2023). «Cancer Neuroscience: State of the Field, Emerging Directions». Cell 186 (8): 1689–1707. doi:10.1016/j.cell.2023.02.002. PMID 37059069.

nih.gov

«The 2007 WHO classification of tumours of the central nervous system». Acta Neuropathol 114 (2): 97–109. August 2007. doi:10.1007/s00401-007-0243-4. PMID 17618441.
«Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis». Surg Neurol 60 (5): 443–56. November 2003. doi:10.1016/s0090-3019(03)00167-8. PMID 14572971.
Ostrom, Quinn T.; Gittleman, Haley; Liao, Peter; Vecchione-Koval, Toni; Wolinsky, Yingli; Kruchko, Carol; Barnholtz-Sloan, Jill S. (October 2017). «CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014». Neuro-Oncology 19 (S5): v1–v88. doi:10.1093/neuonc/nox158. PMID 29117289.
«Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors». Cancer 35 (5): 1398–404. May 1975. doi:10.1002/1097-0142(197505)35:5<1398::aid-cncr2820350524>3.0.co;2-c. PMID 1122488. https://archive.org/details/sim_cancer_1975-05_35_5/page/n149.
Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, Gutmann DH, Hervey-Jumper S, Kuner T, Mabbott D, Platten M, Rolls A, Sloan EK, Wang TC, Wick W, Venkataramani V, Monje M (April 2023). «Cancer Neuroscience: State of the Field, Emerging Directions». Cell 186 (8): 1689–1707. doi:10.1016/j.cell.2023.02.002. PMID 37059069.

Radboud universitair medisch centrum. «highly malignant oligodendroglioma, grade IV» (PDF). www.radboudumc.nl/ (στα Ολλανδικά).

«Radiosurgery/Cyberknife». Stanford School of Medicine. Αρχειοθετήθηκε από το πρωτότυπο στις 3 Σεπτεμβρίου 2007. Ανακτήθηκε στις 8 Φεβρουαρίου 2019.

Schweizerische Hirntumor Stiftung. «Anaplastisches Oligodendrogliom». www.swissbraintumorfoundation.com/ (στα Γερμανικά).

administrador (5 February 2020). «Anaplastic oligodendroglioma, IDH-mutant & 1p/19q-codeleted» (στα αγγλικά). Αρχειοθετήθηκε από το πρωτότυπο στις 2022-06-21. https://web.archive.org/web/20220621095140/https://operativeneurosurgery.com/doku.php?id=anaplastic_oligodendroglioma_idh-mutant_1p_19q-codeleted. Ανακτήθηκε στις 2023-04-23.
«Radiosurgery/Cyberknife». Stanford School of Medicine. Αρχειοθετήθηκε από το πρωτότυπο στις 3 Σεπτεμβρίου 2007. Ανακτήθηκε στις 8 Φεβρουαρίου 2019.